Who are Metformin and Insulin sc's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/metformin-and-insulin-sc.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Metformin and Insulin sc — Competitive Intelligence Brief

Metformin and Insulin sc (Metformin and Insulin sc) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: SGLT2 inhibitor and insulin. Area: Diabetes.

phase 3 SGLT2 inhibitor and insulin Diabetes Small molecule Live · refreshed every 30 min

Target snapshot

Metformin and Insulin sc (Metformin and Insulin sc) — Institut für Pharmakologie und Präventive Medizin. Metformin works by decreasing glucose production in the liver and increasing insulin sensitivity, while insulin sc works by replacing or supplementing the body's natural insulin.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Metformin and Insulin sc TARGET	Metformin and Insulin sc	Institut für Pharmakologie und Präventive Medizin	phase 3	SGLT2 inhibitor and insulin

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (SGLT2 inhibitor and insulin class)

Institut für Pharmakologie und Präventive Medizin · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Metformin and Insulin sc — Competitive Intelligence Brief. https://druglandscape.com/ci/metformin-and-insulin-sc. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab